TruBridge, Inc. TBRG

Updated: 10 Aug 2026

NASDAQ | Technology | Healthcare technology solutions

No signal published yet

We already track TruBridge and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.

Follow TruBridge free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Free
No email, no account, no signup.
Exchange
NASDAQ
Type
Technology
Sector
Healthcare technology solutions
We're already tracking TruBridge, Inc. — here are the latest events we've registered

Recent News

  • On July 10, 2026, IKS Health completed its acquisition of TruBridge in an all-cash transaction valued at $26.25 per share. Following the deal, TruBridge ceased trading and was delisted from the Nasdaq exchange on July 9, 2026.

What Firelda Watch includes for TruBridge, Inc.

Add the company to your watchlist and get all of this automatically.

  • Free: 3 companies on your watchlist
  • Change history and monitoring for every company you follow
  • Sunday weekly brief — a short weekly roundup
  • Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of TruBridge, Inc. will be delivered in the same format.

Want to follow TruBridge, Inc.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.

Follow TruBridge free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

TruBridge, Inc. TBRG
TruBridge — follow and we'll monitor it
Follow TruBridge free Follow free
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.